JCU (4975) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
10 Dec, 2025Executive summary
Net sales for 3Q FY3/25 rose 20.5% year-over-year to ¥20,732 million, with operating profit up 41.8% and net income up 46.5% compared to the same period last year.
Strong recovery in demand for chemicals in China, Taiwan, and South Korea, driven by the electronics and semiconductor sectors; Japan saw a decline due to design trend changes.
Machine Business sales increased substantially, though new large project orders and backlog declined.
The electronics industry saw a recovery in demand, especially for high-performance electronic devices, while the automotive sector remained flat in China.
Financial highlights
Operating profit reached ¥7,636 million, up 41.8% year-over-year; ordinary profit was ¥7,954 million, up 41.2%.
Net income per share rose to ¥217.29 from ¥146.69 year-over-year.
Gross profit margin improved as gross profit rose to ¥13,571 million from ¥10,674 million year-over-year.
Total assets increased to ¥51,260 million, and net assets to ¥45,016 million, with an equity ratio of 87.8%.
Overseas sales ratio for chemicals remained high, with overseas markets accounting for 76-81% of sales.
Outlook and guidance
3Q progress rates against full-year forecasts: net sales 74.0%, operating profit 76.4%, ordinary profit 75.8%, net income 76.2%.
Full-year forecast revised in February 2025: net sales ¥28,000 million, operating profit ¥10,000 million, net income per share ¥285.68.
The company is implementing a new medium-term management plan, focusing on investments in growth markets, digital transformation, and sustainability.
Latest events from JCU
- Profits and sales rose, with higher full-year and dividend forecasts.4975
Q3 20265 Feb 2026 - Strong profit and sales growth, share buyback, and positive full-year outlook.4975
Q1 202510 Dec 2025 - Profits and sales soared on electronics recovery, with robust cash flow and a positive outlook.4975
Q2 202510 Dec 2025 - Double-digit profit growth, higher dividends, and stable FY2026 outlook with currency risk.4975
Q4 202510 Dec 2025 - Strong 1Q profit growth and solid progress toward annual targets, led by chemicals.4975
Q1 202610 Dec 2025 - Strong 1H FY3/26 growth in sales and profit, with positive outlook and higher dividends.4975
Q2 202610 Dec 2025